MAP2 gene
Evidence from:
primary |
all sources
Related entities (3)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| MAP2 | associated_with | AUDIT-C | — | 1 |
| MAP2 | expressed_in | GABA | — | 1 |
| MAP2 | associated_with | SYN1 | — | 1 |
Mentioned in (6)
Papers in which this entity is mentioned.
- Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
- Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. (2023)
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. (2019)
- Different patterns of regional Purkinje cell loss in the cerebellar vermis as a function of the timing of prenatal ethanol exposure in an ovine model. (2013)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| map2 | gene | 48 | 116 |
| map2 | drug | 9 | 12 |
| map2-im | gene | — | — |
| map2 immunostained | gene | — | — |
| microtubule associated protein 2 | gene | — | — |
| microtubule-associated protein 2 | gene | — | — |